4th Quarter - Report

EPILEPSY FOUNDATION for EPILEPSY FOUNDATION

Firm
Client
Income
—
Expenses
$50,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

-H.R. 6420 / S. 3652 All Dependents Count Act, support passage. -H.R. 6680 / S. 3619 Strengthening Unemployment Insurance for Coronavirus Impacted Workers and Students Act, support passage. -H.R. 6305 / S. 3544 Coronavirus Relief for Seniors and People with Disabilities, support passage. -H.R. 2279/S. 2546, Safe Step Act, support passage-H.R. 3630, No Surprises Act; S. 1895, Lower Health Care Costs Act; S. 1531, the Stopping the Outrageous Practice of Surprise Medical Bills Act of 2019; H.R. 5800, Ban Surprise Billing Act; H.R. 5826 Consumer Protections Against Surprise Medical Bills Act, support passage of legislation to protect patients from surprise medical billing that holds patients harmless-H.R. 2093/S. 1028, STATES Act, support passage-H.R. 127, Compassionate Access, Research Expansion and Respect States (CARERS) Act, support passage- H.R. 4322/S. 2400, Expanding Cannabis Research and Information Act, support passage -H.R. 1425, Patient Protection and Affordable Care Enhancement Act, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.

LobbyistCovered position, as disclosed
RACHEL PATTERSON —
ABBEY ROUDEBUSH —
LAURA WEIDNER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 127 (116th), H.R. 6420 (116th), S. 1028 (116th), S. 3652 (116th), H.R. 2093 (116th), S. 1531 (116th), H.R. 5800 (116th), H.R. 133 (116th), H.R. 1425 (116th), H.R. 3630 (116th), S. 3544 (116th), S. 1895 (116th), S. 2400 (116th), H.R. 6305 (116th), S. 2546 (116th), H.R. 6680 (116th), H.R. 5826 (116th), H.R. 2279 (116th), S. 3619 (116th), H.R. 4322 (116th)

Budget/Appropriations BUD

-H.R. 7614, Labor, Health and Human Services, Education and Related Agencies Appropriations Act, 2021, support funding for epilepsy programs and research including $11.5 million for the CDCs Epilepsy program, $44.7 billion for the NIH and $5 million for the National Neurological Conditions Surveillance System, and $10 million for Lifespan Respite Care Program -H.R. 7610, Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations Act, 2021, support robust funding for the Food & Drug Administration. -H.R. 7617, Defense Appropriations Act, 2021, support robust funding for the Congressionally Directed Medical Research Programs. -H.R. 7617, Defense, Commerce, Justice, Science, Energy and Water Development, Financial Services and General Government, Labor, Health and Human Services, Education, Transportation, Housing, and Urban Development Appropriations Act, 2021, support passage. -H.R. 133, Consolidated Appropriations Act, support funding for epilepsy programs and research, COVID-19 relief and ending surprise medical billing.

LobbyistCovered position, as disclosed
RACHEL PATTERSON —
ABBEY ROUDEBUSH —
LAURA WEIDNER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 133 (116th), H.R. 7614 (116th), H.R. 7617 (116th), H.R. 7610 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.